Literature DB >> 21382739

Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: a review.

Martijn Broen1, Annelien Duits, Veerle Visser-Vandewalle, Yasin Temel, Ania Winogrodzka.   

Abstract

Recently, impulse control and related disorders including punding and the dopamine dysregulation syndrome (DDS) have been increasingly recognized in treated patients with Parkinson's disease (PD). Especially the impulse control disorders (ICD) such as pathological gambling, hypersexuality, compulsive eating and buying may have dramatic repercussions on family, personal and professional life. Drug replacement therapy (DRT) is believed to play an important role in the onset of these behavioral disturbances. Although deep brain stimulation (DBS) of the subthalamic nucleus (STN) might be a therapeutic option for those patients with DRT-related behavior, it may also induce ICD. So far, little is known about the relationship between STN DBS and impulse control and related disorders. Our aim was to review the current knowledge on this relationship in PD patients. The available studies showed that stimulation of the STN is associated with both favorable and negative outcome in terms of impulse control and related disorders. Preoperative disorders may resolve or improve after STN DBS, but these can also worsen or show no change at all. Moreover, STN DBS can also reveal or even induce ICD. Possible explanations for this variability are proposed and suggestions for clinical management are given.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21382739     DOI: 10.1016/j.parkreldis.2011.02.013

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  36 in total

1.  Management of sexual dysfunction in Parkinson's disease.

Authors:  Gila Bronner; David B Vodušek
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

2.  Zoophilia and impulse control disorder in a patient with Parkinson disease.

Authors:  Gabriela Raina; Maria Graciela Cersosimo; Federico Micheli
Journal:  J Neurol       Date:  2011-11-05       Impact factor: 4.849

3.  Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy?

Authors:  Rupam Borgohain; Rukmini Mridula Kandadai; Afshan Jabeen; Meena A Kannikannan
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

Review 4.  Impulsive and compulsive behaviors in Parkinson's disease.

Authors:  B B Averbeck; S S O'Sullivan; A Djamshidian
Journal:  Annu Rev Clin Psychol       Date:  2013-12-02       Impact factor: 18.561

5.  Betting on DBS: Effects of subthalamic nucleus deep brain stimulation on risk taking and decision making in patients with Parkinson's disease.

Authors:  Jason Brandt; Mark Rogerson; Haya Al-Joudi; Gila Reckess; Barnett Shpritz; Chizoba C Umeh; Noha Aljehani; Kelly Mills; Zoltan Mari
Journal:  Neuropsychology       Date:  2014-12-08       Impact factor: 3.295

6.  Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study.

Authors:  Daniel Weintraub; Kimberly Papay; Andrew Siderowf
Journal:  Neurology       Date:  2013-01-08       Impact factor: 9.910

Review 7.  [Deep brain stimulation for movement disorders].

Authors:  F Steigerwald; J Volkmann
Journal:  Nervenarzt       Date:  2012-08       Impact factor: 1.214

Review 8.  Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits.

Authors:  Samuel S Pappas; Daniel K Leventhal; Roger L Albin; William T Dauer
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

9.  Treatment of Gambling Disorders.

Authors:  Sarah W Yip; Marc N Potenza
Journal:  Curr Treat Options Psychiatry       Date:  2014-06-01

Review 10.  Sleep in Parkinson's Disease with Impulse Control Disorder.

Authors:  Michela Figorilli; Patrizia Congiu; Rosa Lecca; Gioia Gioi; Roberto Frau; Monica Puligheddu
Journal:  Curr Neurol Neurosci Rep       Date:  2018-08-11       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.